Mutations in the kinesin KIF1A cause impaired axonal transport, resulting in neurological disorders or neurodevelopmental disorders known as KIF1A-associated neurological disorder (KAND). In clinical practice, there is limited knowledge about effective interventions and treatments for these mutations.